IL146568A0 - Hydrochloride salt of a fused heterocyclic compound and pharmaceutical compositions containing the same - Google Patents

Hydrochloride salt of a fused heterocyclic compound and pharmaceutical compositions containing the same

Info

Publication number
IL146568A0
IL146568A0 IL14656800A IL14656800A IL146568A0 IL 146568 A0 IL146568 A0 IL 146568A0 IL 14656800 A IL14656800 A IL 14656800A IL 14656800 A IL14656800 A IL 14656800A IL 146568 A0 IL146568 A0 IL 146568A0
Authority
IL
Israel
Prior art keywords
same
pharmaceutical compositions
compositions containing
hydrochloride salt
heterocyclic compound
Prior art date
Application number
IL14656800A
Other languages
English (en)
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15340495&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL146568(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IL146568A0 publication Critical patent/IL146568A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL14656800A 1999-05-24 2000-05-24 Hydrochloride salt of a fused heterocyclic compound and pharmaceutical compositions containing the same IL146568A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14351399 1999-05-24
PCT/JP2000/003325 WO2000071540A1 (en) 1999-05-24 2000-05-24 Hydrochloride of fused-heterocycle compound

Publications (1)

Publication Number Publication Date
IL146568A0 true IL146568A0 (en) 2002-07-25

Family

ID=15340495

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14656800A IL146568A0 (en) 1999-05-24 2000-05-24 Hydrochloride salt of a fused heterocyclic compound and pharmaceutical compositions containing the same

Country Status (25)

Country Link
US (1) US6706746B2 (de)
EP (1) EP1180519B1 (de)
KR (2) KR100748053B1 (de)
CN (1) CN1156473C (de)
AT (1) ATE294799T1 (de)
AU (1) AU763731B2 (de)
BR (1) BR0010914A (de)
CA (1) CA2375017C (de)
CZ (1) CZ297927B6 (de)
DE (1) DE60019919T2 (de)
DK (1) DK1180519T3 (de)
ES (1) ES2240099T3 (de)
HK (1) HK1042087B (de)
HU (1) HU229340B1 (de)
IL (1) IL146568A0 (de)
MX (1) MXPA01012044A (de)
NO (1) NO321578B1 (de)
NZ (1) NZ515570A (de)
PL (1) PL209389B1 (de)
PT (1) PT1180519E (de)
RU (1) RU2214410C2 (de)
TR (1) TR200103353T2 (de)
TW (1) TWI284533B (de)
WO (1) WO2000071540A1 (de)
ZA (1) ZA200109576B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI284533B (en) * 1999-05-24 2007-08-01 Sankyo Co Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant
EP1695716A2 (de) 2000-12-26 2006-08-30 Sankyo Company, Limited Medizinische Zusammensetzungen enthaltend ein Diuretikum und einen Insulin-Sensibilisator
US6756399B2 (en) * 2001-06-29 2004-06-29 The United States Of America As Represented By The Department Of Health And Human Services Use of lipoxygenase inhibitors and PPAR ligands as anti-cancer therapeutic and intervention agents
WO2003082865A1 (en) * 2002-04-01 2003-10-09 Sankyo Company, Limited Medicinal antitumor composition
WO2004013109A1 (ja) * 2002-08-02 2004-02-12 Sankyo Company, Limited レゾルシノール誘導体
US7781464B2 (en) * 2003-01-17 2010-08-24 Bexel Pharmaceuticals, Inc. Heterocyclic diphenyl ethers
US7521465B2 (en) * 2003-01-17 2009-04-21 Bexel Pharmaceuticals, Inc. Diphenyl ether derivatives
US6794401B2 (en) * 2003-01-17 2004-09-21 Bexel Pharmaceuticals, Inc. Amino acid phenoxy ethers
US7718377B2 (en) 2003-05-29 2010-05-18 Kyoto Pharmaceutical Industries, Ltd. Insulin resistance curative and method of screening the same
US7087576B2 (en) * 2003-10-07 2006-08-08 Bexel Pharmaceuticals, Inc. Dipeptide phenyl ethers
CA2543452C (en) * 2003-10-24 2012-03-13 Santen Pharmaceutical Co., Ltd. Therapeutic agent for keratoconjunctival disorder
EP1566202A1 (de) * 2004-02-23 2005-08-24 Sahltech I Göteborg AB Verwendung von resistin-antagonisten zur behandlung von Rheumatoider arthritis
CN1972715A (zh) * 2004-03-29 2007-05-30 三共株式会社 含有胰岛素抵抗改善剂的糖尿病治疗剂
TW200608967A (en) 2004-07-29 2006-03-16 Sankyo Co Pharmaceutical compositions containing with diabetic agent
CA2590883A1 (en) * 2004-12-13 2006-06-22 Daiichi Sankyo Company, Limited Medicinal composition for treating diabetes
CN101115483A (zh) * 2004-12-15 2008-01-30 第一三共株式会社 含有FBPase抑制剂的药物组合物
TW200637856A (en) 2005-01-24 2006-11-01 Sankyo Co Process for producing thiazolidinedion compound and intermediate thereof
TW200722088A (en) * 2005-05-27 2007-06-16 Sankyo Co Diabetes remedy
EP1902713A4 (de) * 2005-07-08 2009-05-13 Daiichi Sankyo Co Ltd Eine thiazolidindion-verbindung enthaltende pharmazeutische zusammensetzung
TW200738266A (en) * 2005-09-29 2007-10-16 Sankyo Co Pharmaceutical agent containing insulin resistance improving agent
KR101409705B1 (ko) 2005-11-28 2014-07-14 센주 세이야꾸 가부시키가이샤 Ｐｐａｒ 아고니스트 함유 의약
TW200838512A (en) * 2007-02-08 2008-10-01 Daiichi Sankyo Co Ltd Crystalline forms of a thiazolidinedione compound and manufacturing methods thereof
BRPI0809643A2 (pt) * 2007-04-05 2014-11-11 Daiichi Sankyo Co Ltd Derivados de heteroarila bicíclica fundida
CN101801941B (zh) 2007-05-21 2012-12-12 千寿制药株式会社 含有ppar△激动剂的药物
US8722710B2 (en) 2007-09-26 2014-05-13 Deuterx, Llc Deuterium-enriched pioglitazone
EP2404918B1 (de) 2009-03-05 2016-11-30 Daiichi Sankyo Company, Limited Pyridinderivat als ppary inhibitor
AU2014236510A1 (en) 2013-03-14 2015-09-24 Deuterx, Llc Deuterium-enriched 2,4-thiazolidinediones and methods of treatment
ES2831326T3 (es) 2014-01-15 2021-06-08 Poxel Sa Métodos para tratar trastornos neurológicos, metabólicos y otros mediante el uso de pioglitazona enantiopura enriquecida con deuterio
US11319313B2 (en) 2020-06-30 2022-05-03 Poxel Sa Crystalline forms of deuterium-enriched pioglitazone
US11767317B1 (en) 2020-06-30 2023-09-26 Poxel Sa Methods of synthesizing enantiopure deuterium-enriched pioglitazone

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143930A (en) * 1990-02-07 1992-09-01 Sankyo Company, Limited Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
IL118474A (en) * 1995-06-01 2001-08-08 Sankyo Co Benzimideol derivatives and pharmaceutical preparations containing them
HUP9601808A3 (en) 1995-07-03 2000-06-28 Sankyo Co Treatment of arteriosclerosis and xanthoma
TWI284533B (en) * 1999-05-24 2007-08-01 Sankyo Co Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant
PL352681A1 (en) * 1999-07-19 2003-09-08 Sankyo Company, Limited Preventive and therapeutic agents for cancer

Also Published As

Publication number Publication date
HUP0201334A3 (en) 2002-11-28
EP1180519B1 (de) 2005-05-04
BR0010914A (pt) 2002-02-19
ES2240099T3 (es) 2005-10-16
EP1180519A4 (de) 2002-07-10
AU4948700A (en) 2000-12-12
ZA200109576B (en) 2003-02-20
NZ515570A (en) 2003-11-28
DE60019919D1 (de) 2005-06-09
PT1180519E (pt) 2005-06-30
HK1042087B (en) 2005-09-09
DK1180519T3 (da) 2005-06-13
KR20010113972A (ko) 2001-12-28
HUP0201334A2 (en) 2002-10-28
CZ20014182A3 (cs) 2002-04-17
AU763731B2 (en) 2003-07-31
RU2214410C2 (ru) 2003-10-20
EP1180519A1 (de) 2002-02-20
CN1156473C (zh) 2004-07-07
TR200103353T2 (tr) 2002-04-22
PL351650A1 (en) 2003-05-19
US6706746B2 (en) 2004-03-16
CN1364168A (zh) 2002-08-14
NO20015712D0 (no) 2001-11-23
US20020111373A1 (en) 2002-08-15
NO20015712L (no) 2001-12-20
MXPA01012044A (es) 2002-05-06
TWI284533B (en) 2007-08-01
NO321578B1 (no) 2006-06-06
CZ297927B6 (cs) 2007-05-02
PL209389B1 (pl) 2011-08-31
CA2375017C (en) 2009-05-19
HU229340B1 (en) 2013-11-28
KR20070034112A (ko) 2007-03-27
KR100783348B1 (ko) 2007-12-07
HK1042087A1 (en) 2002-08-02
KR100748053B1 (ko) 2007-08-09
WO2000071540A1 (en) 2000-11-30
CA2375017A1 (en) 2000-11-30
DE60019919T2 (de) 2006-02-16
ATE294799T1 (de) 2005-05-15

Similar Documents

Publication Publication Date Title
IL146568A0 (en) Hydrochloride salt of a fused heterocyclic compound and pharmaceutical compositions containing the same
PT976748E (pt) Derivados de pirrolidina com actividade inibidora de fosfolipase a2
AU685116B2 (en) Azolylamine derivative
IL101785A0 (en) Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
HU9500240D0 (en) New prolin-amide derivatives and pharmaceutical compositions containing them as active component
ID28806A (id) Turunan-turunan karboksamida heterosiklik yang mengandung nitrogen atau garam-garam daripadanya dan zat-zat antivirus yang terdiri dari senyawa ini
SG77195A1 (en) Fungicidal 2-methoxybenzophenones
WO2001032652A3 (en) N-substituted carbamoyloxyalkyl-azolium derivatives
EP1227096A4 (de) Antimikrobielle 4-oxochinolizine mit 2-pyridongerüsten als teilstruktur
WO2003053971A8 (en) Pyridoquinoxaline antivirals
DE69818261D1 (en) Hydroxycyclopentanone
EP1026162A4 (de) Antirheumatika
AU6117698A (en) Antiviral agents
AU6418698A (en) Antirheumatic agents
EP0773214A4 (de) Trifluormethylchinolincarbonsäure derivate
CA2349452A1 (en) Therapeutic agents for drug dependence
DE60238847D1 (de) Pyrimidinderivate enthaltendes medikament
EP0651945A4 (de) Mittel zum schutz vor termiten.
AU7962000A (en) Us0027324for eating disorders
EP1211245A4 (de) Mittel zur behandlung von parasiten-verursachten erkrankungen
EP1118327A4 (de) Vorbeugende und/oder therapeutische mittel zur behandlung der sinusitis.
EP0878475A3 (de) 5-(4-Piperidinyl)dibenzothiazepine derivate und 5-(4-piperidinyl)dibenzoxazepinderivate, und antiarrhythmische Mittel
SI0987268T1 (en) Pharmaceutical agents containing epothilone A-N-oxide and/or epothilone B-N-oxide
PL356412A1 (en) New compounds: derivatives of symmetrical 1,3,5- triazine

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees